NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









M20 Genomics

M20 Genomics

Private
HangzhouHealthcare & Life Scienceshttps://www.m20genomics.com/

Last Round

Early Funding

Jun 13, 2022

Company Overview

M20 Genomics is a life science technology company that develops and provides single-cell and spatial transcriptomics sequencing solutions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Precision Medicine

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

single-cell sequencingspatial transcriptomicsscRNA-seqtranscriptome sequencingsingle-cell analysisFFPE tissue analysisspatial biologygene expression analysisNGSnext-generation sequencingrandom primer technologysequencing kitsbioinformatics softwareautomated cell annotationmulti-omics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

M20 Genomics Comparables

Compare M20 Genomics with similar companies based on industry and business-model similarity.

M20 Genomics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Beijing SeekGene BioSciences Co., Ltd.
87%
MobiDrop Biotech
82%
Singleron Biotechnologies
79%

M20 Genomics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingJun 13, 2022
Early FundingApr 29, 2022
AngelDec 1, 2021

M20 Genomics Investors

Notable investors and investment history

M20 Genomics investors
InvestorRounds
Nest.BioEarly Funding, Angel
HongShanEarly Funding
Qiming Venture PartnersEarly Funding, Angel

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 2, 2025

    Monthly visitors increased 1220% MoM, from 59 to 779.

M20 Genomics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

M20 Genomics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about M20 Genomics's valuation, stock price, and market status.

Firmographic Details

HeadquartersHangzhou
Employee Range8
Year Founded2021
Last FundingJun 13, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.